JB CHEMICALS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 12.45% YoY .
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 18.98 % YoY. |
||
JB CHEMICALS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 506943|NSE : JBCHEPHARM]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹3,918 Cr | ₹3,484 Cr | ₹3,149 Cr | ₹2,424 Cr | ₹2,043 Cr |
| Expenses | ₹2,887 Cr | ₹2,592 Cr | ₹2,454 Cr | ₹1,882 Cr | ₹1,486 Cr |
| Operating Profit (Excl OI) | ₹1,031 Cr | ₹892 Cr | ₹696 Cr | ₹543 Cr | ₹556 Cr |
| Other Income | ₹39 Cr | ₹42 Cr | ₹9.94 Cr | ₹40 Cr | ₹117 Cr |
| Interest | ₹12 Cr | ₹44 Cr | ₹36 Cr | ₹5.12 Cr | ₹7.24 Cr |
| Depreciation | ₹171 Cr | ₹138 Cr | ₹114 Cr | ₹73 Cr | ₹69 Cr |
| Profit Before Tax | ₹887 Cr | ₹752 Cr | ₹555 Cr | ₹505 Cr | ₹597 Cr |
| Profit After Tax | ₹660 Cr | ₹553 Cr | ₹410 Cr | ₹386 Cr | ₹449 Cr |
| Consolidated Net Profit | ₹660 Cr | ₹553 Cr | ₹410 Cr | ₹385 Cr | ₹448 Cr |
| Earnings Per Share (Rs) | ₹42.37 | ₹35.61 | ₹52.97 | ₹49.86 | ₹57.96 |
| PAT Margin (%) | 16.25 | 15.33 | 12.54 | 15.51 | 21.96 |
| ROE(%) | 21.81 | 21.49 | 18.51 | 19.89 | 27.64 |
| ROCE(%) | 26.73 | 25.23 | 22.79 | 25.48 | 36.53 |
| Total Debt/Equity(x) | 0.00 | 0.13 | 0.23 | 0.01 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 32,969.6 Cr |
| Revenue (TTM) | : | ₹ 4,193.0 Cr |
| Net Profit(TTM) | : | ₹ 753.8 Cr |
| EPS (TTM) | : | ₹ 46.9 |
| P/E (TTM) | : | 43.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | 0.3% | 9.8% | 29.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% | 9% | 8.6% |
| DIVIS LABORATORIES | 1.9% | 5.9% | 12.6% |
| CIPLA | 1.6% | 1.8% | -7.9% |
| TORRENT PHARMACEUTICALS | 0.6% | 9.5% | 45% |
| DR REDDYS LABORATORIES | -1.5% | 5.7% | 14.5% |
| MANKIND PHARMA | 9.9% | 5.8% | -2% |
| ZYDUS LIFESCIENCES | 1.6% | 4.2% | 6% |
| LUPIN | 2.5% | 7% | 21.9% |
JB CHEMICALS & PHARMACEUTICALS Revenues
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 12.45 % |
| 5 Yr CAGR | 17.69 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,918 Cr | 12.45 | |
| Mar2024 | ₹3,484 Cr | 10.63 | |
| Mar2023 | ₹3,149 Cr | 29.91 | |
| Mar2022 | ₹2,424 Cr | 18.69 | |
| Mar2021 | ₹2,043 Cr | - | |
JB CHEMICALS & PHARMACEUTICALS Operating Profit
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 15.53 % |
| 5 Yr CAGR | 16.69 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,031 Cr | 15.53 | |
| Mar2024 | ₹892 Cr | 28.28 | |
| Mar2023 | ₹696 Cr | 28.22 | |
| Mar2022 | ₹543 Cr | -2.44 | |
| Mar2021 | ₹556 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.73 % |
| 5 Yr CAGR | -0.85 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 26.32% | 2.73 | |
| Mar2024 | 25.62% | 15.98 | |
| Mar2023 | 22.09% | -1.30 | |
| Mar2022 | 22.38% | -17.81 | |
| Mar2021 | 27.23% | - | |
JB CHEMICALS & PHARMACEUTICALS Profit After Tax
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 19.35 % |
| 5 Yr CAGR | 10.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹660 Cr | 19.35 | |
| Mar2024 | ₹553 Cr | 34.84 | |
| Mar2023 | ₹410 Cr | 6.35 | |
| Mar2022 | ₹385 Cr | -13.98 | |
| Mar2021 | ₹448 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 6.00 % |
| 5 Yr CAGR | -7.25 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 16.25 % | 6.00 | |
| Mar2024 | 15.33 % | 22.25 | |
| Mar2023 | 12.54 % | -19.15 | |
| Mar2022 | 15.51 % | -29.37 | |
| Mar2021 | 21.96 % | - | |
JB CHEMICALS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 18.98 % |
| 5 Yr CAGR | -7.53 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 | 18.98 | |
| Mar2024 | ₹36 | -32.77 | |
| Mar2023 | ₹53 | 6.24 | |
| Mar2022 | ₹50 | -13.98 | |
| Mar2021 | ₹58 | - | |
JB CHEMICALS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 5.95 % |
| 5 Yr CAGR | -7.51 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 26.73% | 5.95 | |
| Mar2024 | 25.23% | 10.71 | |
| Mar2023 | 22.79% | -10.56 | |
| Mar2022 | 25.48% | -30.25 | |
| Mar2021 | 36.53% | - | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹2,052.9 |
| Current MarketCap | : | ₹ 32,969.6 Cr |
| Updated EOD on | : | Feb 27,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | 0.3% |
9.8% |
29.7% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE HEALTHCARE | 1.9% | 7.3% | 9.1% |
| BSE 400 MIDSMALLCAP INDEX | -0.5% | 1.5% | 10.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY PHARMA | 2.2% | 6.4% | 10.4% |
| NIFTY MNC | 1.6% | 4% | 22% |
| NIFTY500 MULTICAP INDIA MANUFACTURING 50:30:20 | 0.6% | 4% | 17.3% |
| NIFTY 500 EQUAL WEIGHT | -0.4% | 2% | 10.6% |
| NIFTY MIDSMALLCAP 400 | -0.4% | 1.7% | 12.8% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS Financials
How the annual revenues of JB CHEMICALS & PHARMACEUTICALS have changed ?
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 12.45% YoY .
How the Earnings per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 18.98 % YoY .
Check out Intrinsic Value of Peers of JB CHEMICALS & PHARMACEUTICALS
Compare Stock Analytics of Peers of JB CHEMICALS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
